Related Experiment Video
Updated: Jun 4, 2025

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Lymphoma combined with lung cancer: A case report
Dandan Zhang1, Jianping Liang1, Yanhua Lv1
1Department of Respiratory and Critical Care Medicine, Zhongshan City People's Hospital, China.
Abstract:
Lymphoma originates from the lymphatic hematopoietic system and is prone to develop second tumors. We reported a case of lymphoma initially manifesting systematic lymphadenopathies and lung space-occupying lymphoma that developed to lung squamous cell carcinoma in 30 months. The diseases once responded satisfactorily to chemotherapy combined with immunotherapy but progressed after 8 months. Following afatinib administration achieved sustained remission and the progression-free survival is 11 months. Rarely does lymphoma combine with lung cancer and more rarely does lung cancer develop in the original focus of pulmonary lymphoma; first-line and secondary treatment remained potent in treating the complexity.

